Tariffs and Trade Series: What Senior Management Teams Need to Know
No Password Required: CEO of HACKERverse.ai, Disruptor of Cybersecurity Sales and Most Other Things
Compliance Tip of the Day: Multiplying the Influence of Compliance
Daily Compliance News: May 13, 2025, The Leaving on a Jet Plane Edition
Compliance tip of the Day: Communication Through Persuasion
FCPA Compliance Report: Upping Your Game in Compliance
Episode 368 — LRN Issues New Report Highlighting Growing Gap in Compliance Program Performance
Compliance Tip of the Day: Empowering Middle Managers to Drive Compliance Transformation
Creativity and Compliance: From Compliance Enforcers to Trusted Advisors: The Path Forward
Top Healthcare Compliance Priorities for 2025
Compliance Tip of the Day: Middle Managers as the Eyes and Ears of Compliance
ADA Compliance for Medical and Dental Practices: Responding to Inquiries and Investigations
Innovation in Compliance: Exploring the Intersection of Compliance, Technology, and AI with Ben Sperry
What Every Law Firm Leader Can Learn from Law Day and the Perkins Coie Ruling: On Record PR
Compliance Tip of the Day: Elevating Compliance Through Connected Middle Managers
Compliance into the Weeds: USRA Declination Case Study - Self-Disclosure Best Practices
Compliance Tip of the Day: Middle Managers as Ethical Cornerstones
Understanding Human Trafficking and Modern Slavery: A Business Imperative with Clint Palermo
SBR Author’s Podcast: Understanding Complexity with Dr. Jean Boulton, Part 2: The Power of Simple Principles in Ethics and Compliance
Daily Compliance News: May 6, 2025 the Made in China Edition
On April 10, 2025, Italian fashion house Prada announced its acquisition of Versace from Capri Holdings for $1.375 billion, uniting two of Italy’s most iconic luxury brands. Though financial implications have grabbed...more
This post is the fifth in our five-part series, Navigating Life Sciences Transactions, where our team of attorneys provides essential strategies and insights for successful life sciences transactions. Throughout this series,...more
Due in part to the Bayh-Dole Act of 1980, which incentivized universities to commercialize their technology, the number of academic spinouts has grown in recent years. This is particularly true in the life sciences space,...more
Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies. These challenges often center on intellectual property (IP) risks, licensing...more
Due diligence is a necessary part of any M&A transaction. This process can be an exhaustive deep dive into the target company’s history. In some cases, the buyer wants to assure itself of certain highly confidential and...more
In our ever-changing technological environment, artificial intelligence (AI) is beginning to exert its influence on numerous sectors, revolutionizing our approach to work. As businesses and organizations worldwide adopt...more
The job of a corporate decision-maker is far from easy. Whether you work for a fledgling startup or a Fortune 500 company, each day can present new and daunting obstacles that make it difficult to successfully navigate—let...more
During a merger or an acquisition, businesses have a lot to focus on. Amid negotiations, regulatory compliance, and personnel issues, your brand, and how it is protected, can get overlooked....more
Steven Saunders outlines the role of IP in corporate transactions, what investors and acquirers do, how to conduct IP due diligence, how to make your IP stand out, how to drive your IP assets to support your story, how an IP...more